UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 396

Sortiert nach

The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis

Clinical and experimental rheumatology, 2016-09, Vol.34 (5 Suppl 101), p.S40

2016

Link zum Volltext

Verfügbarkeit prüfen

The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

Journal of lipid research, 2007-04, Vol.48 (4), p.751-762

2007

Link zum Volltext

Verfügbarkeit prüfen

The Disease Activity Score and the EULAR Response Criteria

Rheumatic diseases clinics of North America, 2009-11, Vol.35 (4), p.745-757

2009

Link zum Volltext

Verfügbarkeit prüfen

Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study

Annals of the rheumatic diseases, 2017-10, Vol.76 (10), p.1693

2017

Link zum Volltext

Verfügbarkeit prüfen

The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.998-1003

2015

Link zum Volltext

Verfügbarkeit prüfen

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial

The Lancet (British edition), 2008-05, Vol.371 (9627), p.1854-1860

2008

Link zum Volltext

Verfügbarkeit prüfen

Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open‐Label Randomized Controlled Trial

Arthritis & rheumatology (Hoboken, N.J.), 2016-08, Vol.68 (8), p.1810-1817

2016

Link zum Volltext

Verfügbarkeit prüfen

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis

PloS one, 2017-03, Vol.12 (3), p.e0174656-e0174656

2017

Link zum Volltext

Verfügbarkeit prüfen

How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis

BMC musculoskeletal disorders, 2014-11, Vol.15 (1), p.368-368, Article 368

2014

Link zum Volltext

Verfügbarkeit prüfen

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Annals of the rheumatic diseases, 2011-09, Vol.70 (9), p.1575-1580

2011

Link zum Volltext

Verfügbarkeit prüfen

Burden of disease in treated rheumatoid arthritis patients: Going beyond the joint

Seminars in arthritis and rheumatism, 2014-02, Vol.43 (4), p.479-488

2014

Link zum Volltext

Verfügbarkeit prüfen

Induction of nocebo and placebo effects on itch and pain by verbal suggestions

Pain (Amsterdam), 2011-07, Vol.152 (7), p.1486-1494

2011

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Arthritis research & therapy, 2016-02, Vol.18 (50), p.50-50, Article 50

2016

Link zum Volltext

Verfügbarkeit prüfen

Rituximab treatment in patients with refractory inflammatory myopathies

Rheumatology (Oxford, England), 2011-12, Vol.50 (12), p.2206-2213

2011

Link zum Volltext

Verfügbarkeit prüfen

Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs

Journal of rheumatology, 2009-10, Vol.36 (10), p.2164

2009

Link zum Volltext

Verfügbarkeit prüfen

Does Etanercept Biosimilar Prescription in a Rheumatology Center Bend the Medication Cost Curve?

Journal of rheumatology, 2021-12, Vol.48 (12), p.1803

2021

Link zum Volltext

Verfügbarkeit prüfen

A tailored-guided internet-based cognitive-behavioral intervention for patients with rheumatoid arthritis as an adjunct to standard rheumatological care: results of a randomized controlled trial

Pain (Amsterdam), 2017-05, Vol.158 (5), p.868-878

2017

Link zum Volltext

Verfügbarkeit prüfen

Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries

Rheumatology (Oxford, England), 2017-07, Vol.56 (7), p.1102-1110

2017

Link zum Volltext

Verfügbarkeit prüfen

Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort

Arthritis research & therapy, 2012-11, Vol.14 (6), p.R254-R254

2012

Link zum Volltext

Verfügbarkeit prüfen

Patient Self-Management and Tracking: A European Experience

Rheumatic diseases clinics of North America, 2019-05, Vol.45 (2), p.187-195

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial

Arthritis research & therapy, 2015-05, Vol.17 (1), p.134-134, Article 134

2015

Link zum Volltext

Verfügbarkeit prüfen

Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry

BMC musculoskeletal disorders, 2013-12, Vol.14 (1), p.350-350, Article 350

2013

Link zum Volltext

Verfügbarkeit prüfen

Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

Annals of the rheumatic diseases, 2013-06, Vol.72 (6), p.895-900

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 396

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(334)
Mit Volltextzugriff
(313)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(305)
Humans
(299)
Life Sciences & Biomedicine
(295)
Rheumatology
(245)
Rheumatoid Arthritis
(193)
Female
(191)
Male
(189)
Middle Aged
(168)
Adult
(131)
Aged
(129)
Arthritis, Rheumatoid - Drug Therapy
(129)
Biological And Medical Sciences
(124)
Medical Sciences
(121)
Diseases Of The Osteoarticular System
(99)
Antirheumatic Agents - Therapeutic Use
(92)
Inflammatory Joint Diseases
(91)
Severity Of Illness Index
(85)
Treatment Outcome
(71)
Arthritis, Rheumatoid - Diagnosis
(51)
Arthritis, Rheumatoid - Physiopathology
(48)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis

The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

The Disease Activity Score and the EULAR Response Criteria

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study

The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial

Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open‐Label Randomized Controlled Trial

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis

How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Burden of disease in treated rheumatoid arthritis patients: Going beyond the joint

Induction of nocebo and placebo effects on itch and pain by verbal suggestions

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Rituximab treatment in patients with refractory inflammatory myopathies

Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs

Does Etanercept Biosimilar Prescription in a Rheumatology Center Bend the Medication Cost Curve?

A tailored-guided internet-based cognitive-behavioral intervention for patients with rheumatoid arthritis as an adjunct to standard rheumatological care: results of a randomized controlled trial

Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries

Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort

Patient Self-Management and Tracking: A European Experience

Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial

Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry

Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

Suchergebnisse filtern